Archived articles


New method aims to optimize HIV treatments
Published Feb 23, 2024
Johns Hopkins team develops a way to personalize antiretroviral therapy to reduce side effects 
Exploring sex-specific features of HIV
Published Feb 6, 2024
Johns Hopkins researcher Eileen Scully advocates for including sex as a biological variable in preclinical and clinical trials
Biomolecular engineering
Could hydrogel make HIV therapy more convenient?
Published Sept 25, 2023
Injectable solution that self-assembles into a gel could help manage HIV unlike any currently available methods
Public health
Ending the HIV epidemic
Published Aug 1, 2022
Experts from Johns Hopkins and advocacy groups publish a special journal issue dedicated to the issue of HIV prevention through pre-exposure prophylaxis
Immune response
Risk of breakthrough COVID-19 infection higher among people with HIV
Published June 7, 2022
Finding suggests that all people with HIV might benefit from additional dose in primary vaccination
A place to heal
Published Spring 2020
Susan Sherman's SPARC Center serves some of the Baltimore's most vulnerable. / Johns Hopkins Magazine
Global health
Study compares HIV risk among three common methods of contraception
Published June 13, 2019
ECHO trial in eastern and southern Africa shows high incidence of HIV infection among study participants despite extensive HIV prevention counseling
Immune system
Hopkins study examines patients with rare natural ability to suppress HIV
Published Dec 26, 2018
Findings suggest that patients can be in 'HIV remission' despite having a large reservoir of infected cells
Opioid epidemic
Public support remains low for needle exchanges, safe injection sites
Published July 19, 2018
Despite growing concerns over the opioid epidemic, majority of Americans don't support proven harm-reduction programs, study finds
A new milestone in HIV-positive organ donation
Published Jan 11, 2018
Johns Hopkins is the first center in the U.S. approved for living donor HIV-positive to HIV-positive kidney transplants